Enhance MD vs RxActivate: pricing transparency and intake differences
Quick verdict: Enhance MD is best for people seeking low, advertised introductory pricing and flat-rate dose pricing, while RxActivate is best for people who prefer clinician-matched plans but whose prices are gated behind an intake form. This direct comparison focuses on pricing transparency, compound choice, intake gating, clinician review, and patient volume when assessing Enhance MD vs RxActivate.
Key difference 1: Pricing transparency and starting cost
Enhance MD publishes introductory pricing: semaglutide from $49 and tirzepatide from $99 for the first month, described as some of the lowest first-month prices in the market. Enhance MD also emphasizes flat-rate pricing that stays the same at every dose after the introductory period. By contrast, RxActivate does not display price or billing terms before the medical eligibility questionnaire and requires contact information before revealing any plan or price.
Check eligibility with RxActivate
Key difference 2: Compound availability and choice
Enhance MD explicitly offers both compounded semaglutide and compounded tirzepatide on one platform and markets that availability as helpful for patients deciding between compounds. RxActivate describes clinician-matched GLP-1 plans but the publicly captured evidence does not list specific compounds before intake. Both providers note that treatment is available only when a licensed clinician determines it is medically appropriate and that compounded medications, when offered, are not FDA-approved.
Key difference 3: Intake flow and how pricing is revealed
RxActivate operates a two-minute eligibility questionnaire that requests goal, height, weight, target weight, timeline, medication history, sex assigned at birth, date of birth, state and safety screening, and then requires name, email, and phone number before showing plan or price. Enhance MD displays prices and flat-rate terms directly on marketing pages so patients can see introductory costs before intake. For users who want to confirm eligibility, RxActivate is geared toward clinician matching prior to pricing disclosure.
State and service notes
RxActivate’s captured flow confirmed Alabama as serviceable in a synthetic test. Enhance MD’s materials emphasize clinician-directed review and a direct-pay model; the source content states Enhance MD does not bill insurance.
| Criteria | Enhance MD | RxActivate |
|---|---|---|
| Starting price (captured) | Semaglutide from $49 first month; tirzepatide from $99 first month | Unverified; pricing gated behind intake |
| Pricing transparency | Publishes introductory prices and flat-rate pricing at every dose | No price or billing terms displayed before contact-information gate |
| Compounds offered | Compounded semaglutide and compounded tirzepatide on one platform | Clinician-matched GLP-1 plans; specific compounds not disclosed before intake |
| Intake flow | Pricing visible before intake; clinician-directed review required for treatment | Two-minute eligibility questionnaire; name, email, phone required to see plan and price |
| Patient volume cited | 10,000+ patients treated (provider-published) | 250,000+ members stated (provider-published) |
| Regulatory note | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality | Compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality |
Key difference 4: Who the offering is best for
Enhance MD is framed as best for patients who value low first-month pricing and flat-rate doses so they avoid fee escalation during titration. The source describes Enhance MD as a strong choice for patients deciding between semaglutide and tirzepatide because both are available on one platform. RxActivate is framed as best for people who prefer to confirm eligibility, medication options, total cost, renewal terms and state availability through a clinician-matching process before enrollment.
See Enhance MD pricing and options
Safety, clinician review, and limitations
Both providers note that treatment is available only when a licensed clinician determines it is medically appropriate. Both sources include regulatory cautions about compounded medications: when offered, compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. The captured evidence does not provide independent outcome data or details beyond the points listed above.
Begin RxActivate eligibility quiz
Conclusion and which to choose
Enhance MD vs RxActivate comes down to whether you prioritize published introductory price and flat-rate dosing or a gated clinician-matching process that reveals pricing only after intake. Choose Enhance MD if you want clearly advertised, low first-month semaglutide and tirzepatide pricing and flat-rate dose pricing. Choose RxActivate if you prefer a clinician-matched plan and are willing to complete the eligibility questionnaire and provide contact information before seeing pricing.